Two types of CD47-high diffuse large B-cell lymphoma, not otherwise specified. (A) Schematic illustration of the differences between intestinal and nonintestinal type CD47-high DLBCL. (B) Proportion of advanced Ann Arbor stage according to cell of origin and CD47 status in patients with intestinal DLBCL. (C) Difference in cell of origin of intestinal and nonintestinal DLBCLs according to CD47 status. (D) Differences in CD68 and CD8 ratios according to tumor locations and CD47 status. (E) MUM1 immunostaining results (review of electronic medical records) according to tumor locations and CD47 status. This graph shows high homogeneity of tumor cells of intestinal CD47-high DLBCL that is different from that of other site lymphomas.